Table 1 Primary disease sites in patients with EPSCC in South East England, 1970–2004
Disease site | Number of Patients (%) | Location | (n) | Ratio (M:F) | Stage (n) [LD; ED; U] |
|---|---|---|---|---|---|
Head and Neck | 182 (11%) | Trachea | 50 | 1:1.1 | 64; 30; 88 |
Thyroid | 41 | ||||
Larynx | 34 | ||||
Oral Cavity | 22 | ||||
Sino-nasal | 19 | ||||
Pharynx | 12 | ||||
Others | 2 | ||||
Gastrointestinal | 532 (33%) | Oesophagus | 293 | 1:1.3 | 181; 159; 192 |
Stomach | 92 | ||||
Colorectal | 60 | ||||
Pancreas | 55 | ||||
Biliary Tract | 15 | ||||
Others | 17 | ||||
Chest | 115 (7%) | Heart, mediastinum and pleura | 111 | 1.8:1 | 58; 14; 43 |
Others | 4 | ||||
Breast | 167 (10%) | 1:82 | 104; 13; 50 | ||
Genitourinary | 305 (20%) | Prostate | 90 | 1:1 | 109; 86; 110 |
Bladder | 79 | ||||
Cervix | 76 | ||||
Ovary | 44 | ||||
Others | 16 | ||||
Unknown Primary of Lymph Nodes | 69 (4%) | 1:1 | 0; 0; 69 | ||
Others | 248 (15%) | Skin | 11 | 1:1 | 16; 112; 120 |
Others | 237 | ||||
EPSCC | 1618 (100%) | 1:1.3 | 532; 482; 604 | ||
SCLC | 27510 (100%) | 1.7:1 | 9284; 7651; 10575 |